These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. The challenges and promises of new therapies for cystic fibrosis. Pier GB J Exp Med; 2012 Jul; 209(7):1235-9. PubMed ID: 22753926 [TBL] [Abstract][Full Text] [Related]
32. Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator-dependent. Van de Weert-van Leeuwen PB; Van Meegen MA; Speirs JJ; Pals DJ; Rooijakkers SH; Van der Ent CK; Terheggen-Lagro SW; Arets HG; Beekman JM Am J Respir Cell Mol Biol; 2013 Sep; 49(3):463-70. PubMed ID: 23617438 [TBL] [Abstract][Full Text] [Related]
33. Impact of the CFTR-potentiator ivacaftor on airway microbiota in cystic fibrosis patients carrying a G551D mutation. Bernarde C; Keravec M; Mounier J; Gouriou S; Rault G; Férec C; Barbier G; Héry-Arnaud G PLoS One; 2015; 10(4):e0124124. PubMed ID: 25853698 [TBL] [Abstract][Full Text] [Related]
34. Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions. Tam RY; van Dorst JM; McKay I; Coffey M; Ooi CY J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160099 [TBL] [Abstract][Full Text] [Related]
35. Mapping the lung proteome in cystic fibrosis. Gharib SA; Vaisar T; Aitken ML; Park DR; Heinecke JW; Fu X J Proteome Res; 2009 Jun; 8(6):3020-8. PubMed ID: 19354268 [TBL] [Abstract][Full Text] [Related]
36. A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy. Pohl K; Hayes E; Keenan J; Henry M; Meleady P; Molloy K; Jundi B; Bergin DA; McCarthy C; McElvaney OJ; White MM; Clynes M; Reeves EP; McElvaney NG Blood; 2014 Aug; 124(7):999-1009. PubMed ID: 24934256 [TBL] [Abstract][Full Text] [Related]
37. CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease. Fernandez Fernandez E; De Santi C; De Rose V; Greene CM Expert Rev Respir Med; 2018 Jun; 12(6):483-492. PubMed ID: 29750581 [TBL] [Abstract][Full Text] [Related]
38. Bacterial host interactions in cystic fibrosis. Callaghan M; McClean S Curr Opin Microbiol; 2012 Feb; 15(1):71-7. PubMed ID: 22137884 [TBL] [Abstract][Full Text] [Related]
39. A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics. Vernocchi P; Del Chierico F; Quagliariello A; Ercolini D; Lucidi V; Putignani L Nutrients; 2017 Dec; 9(12):. PubMed ID: 29232848 [TBL] [Abstract][Full Text] [Related]
40. Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice. Bertolini A; Nguyen M; Zehra SA; Taleb SA; Bauer-Pisani T; Palm N; Strazzabosco M; Fiorotto R J Hepatol; 2024 Mar; ():. PubMed ID: 38554847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]